Michael T. McCurdy, MD

1999                 BA, The University of Notre Dame

2003                 MD, The University of Texas Medical School at San Antonio

2003-2008                     Resident, Combined Program in Internal Medicine/Emergency Medicine/Critical Care Medicine Departments of Internal Medicine and Emergency Medicine University of Maryland Medical Center

2008-2009                     Fellow, Critical Care Medicine Department of Internal Medicine, University of Maryland Medical Center

Dr. McCurdy is a highly accomplished critical care physician with extensive expertise in managing the most critically ill patients in a variety of settings, from high-acuity academic medical centers to resource-limited environments. Board-certified in Emergency Medicine, Internal Medicine, and Critical Care Medicine, Dr. McCurdy has dedicated his career to the advancement of critical care through clinical practice, research, and medical education. He spent over a decade in the Medical ICU at the University of Maryland Medical Center (UMMC), where he provided lifesaving care to patients suffering from septic shock, multi-organ failure, and other life-threatening conditions. His leadership in critical care medicine was further recognized when he became the Chief of the Department of Medicine and Medical Director of the ICUs at the University of Maryland St. Joseph Medical Center during the COVID-19 pandemic, overseeing patient care in one of Maryland’s top hospitals. As a Clinical Professor at University of Maryland School of Medicine, he remains clinically active in the ICU.

Beyond the bedside, Dr. McCurdy has led groundbreaking research in critical care, publishing extensively in top-tier journals such as the New England Journal of Medicine, JAMA, and Nature. His work has driven innovation in resuscitation, shock state management, and telemedical ultrasound support for remote care providers. As an educator, he created and directed the University of Maryland’s Critical Care Medicine Fellowship, training the next generation of intensivists, including military physicians specializing in critical care for combat and austere environments. His award-winning educational initiatives, including the MarylandCCProject, have provided cutting-edge resources for clinicians worldwide, further solidifying his impact on the field.

Dr. McCurdy’s expertise has also extended into the realm of medical technology and innovation. As the Chief Medical Officer of Clairyon, he leads efforts to harness AI-driven clinical intelligence solutions to predict adverse events and enhance patient outcomes in real time. Previously, he played a pivotal role as Chief Medical Officer of a Boston-based studio VC in advancing DARPA-funded technology designed to rapidly identify and remove pathogens from circulation. His passion for delivering critical care solutions globally is evident in his advisory roles for multiple organizations, as well as his long-standing commitment to improving medical care in resource-limited settings such as St. Luke’s Hospital in Port-au-Prince, Haiti. Whether in the ICU, a field hospital, or a remote austere setting, Dr. McCurdy, as its Chief Medical Officer, ensures that the Nereus team remains at the forefront of critical care innovation, dedicated to delivering timely, thoughtful, and state-of-the-art medical care to its clients in any environment.

shock state management, resuscitation, sepsis

Leisman DE, Wieruszewski PM, Busse LW, Chawla LS, Hibbert KA, Handisides DR, Khanna AK, Ostermann M, McCurdy MT, Adams CD, Hodges TN, Bellomo R;  An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock. ATHOS-3 Investigators. Crit Care. 2025 Feb 19;29(1):81. doi: 10.1186/s13054-025-05311-z.

de Miguel-Perez D, Arroyo-Hernandez M, La Salvia S, Gunasekaran M, Pickering EM, Avila S, Gebru E, Becerril-Vargas E, Monraz-Perez S, Saharia K, Grazioli A, McCurdy MT, Frieman M, Miorin L, Russo A, Cardona AF, García-Sastre A, Kaushal S, Hirsch FR, Atanackovic D, Sahoo S, Arrieta O, Rolfo C. Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19. J Extracell Vesicles. 2024 Nov;13(11):e70001. doi: 10.1002/jev2.70001.PMID: 39558820 Free PMC article.

Leisman DE, Handisides DR, Busse LW, Chappell MC, Chawla LS, Filbin MR, Goldberg MB, Ham KR, Khanna AK, Ostermann M, McCurdy MT, Adams CD, Hodges TN, Bellomo R;  ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock. ATHOS-3 Investigators.Crit Care. 2024 Apr 18;28(1):130. doi: 10.1186/s13054-024-04910-6.PMID: 38637829 Free PMC article. Clinical Trial.

Busse LW, Schaich CL, Chappell MC, McCurdy MT, Staples EM, Ten Lohuis CC, Hinson JS, Sevransky JE, Rothman RE, Wright DW, Martin GS, Khanna AK; Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Investigators.  Association of Active Renin Content With Mortality in Critically Ill Patients: A Post hoc Analysis of the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Trial.  Crit Care Med. 2024 Mar 1;52(3):441-451. doi: 10.1097/CCM.0000000000006095. Epub 2023 Nov 10.PMID: 37947484 Free PMC article.